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Abstract. Because human inmmunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) receives
more donor funding globally than that for all other diseases combined, some critics allege this support undermines
general health care. This empirical study evaluates the impact of HIV/AIDS funding on the primary health care system
in Rwanda. Using a quasi-experimental design, we randomly selected 25 rural health centers (HCs) that started compre-
hensive HIV/AIDS services from 2002 through 2006 as the intervention group. Matched HCs with no HIV/AIDS
services formed the control group. The analysis compared growth in inputs and services between intervention and control
HCs with a difference-in-difference analysis in a random-effects model. Intervention HCs performed better than control
HCs in most services (seven of nine), although only one of these improvements (Bacille Calmette-Gue ´rin vaccination)
reached or approached statistical significance. In conclusion, this six-year controlled study found no adverse effects of the
expansion of HIV/AIDS services on non-HIV services among rural health centers in Rwanda.
INTRODUCTION
The pandemic of human immunodeficiency virus (HIV)
and acquired immunodeficiency syndrome (AIDS) has spread
rapidly since the 1980s. In 2010, 2.7 million new HIV infec-
tions occurred, 1.8 million people died, and 34 million people
were living with HIV infections worldwide.
1 To combat HIV/
AIDS, the international community has provided unprece-
dented financial assistance.
2
This funding for HIV/AIDS has re-opened a long-standing
debate on whether HIV/AIDS funding has strengthened the
health care system of recipient countries to manage other
diseases. Advocates of an enhancement effect of HIV/AIDS
funding believe that the country’s AIDS program has improved
the infrastructure, management, communications, laborato-
ries, information systems, and human resources. Additionally,
they claim that HIV/AIDS funding has contributed to stan-
dardization of services, strengthened monitoring and surveil-
lance systems, better integration of HIV/AIDS service and
primary health care, fewer funding gaps for health care, and
the provision of services that the existing system had been
unable to provide.
3–7
Conversely, critics argue that the infusion of HIV/AIDS
funding weakens the health care system. HIV/AIDS receives
disproportionately more resources than its share of disease
burden, thereby drawing qualified staff from the rest of the
country’s health system and displacing resources that could
have been used for other diseases.
8–10 The investment in
HIV/AIDS may have shifted strategies and commitments of
governments to manage other diseases in a country.
11 These
concerns are bolstered by the fact that approximately one-third
of donor funding on health and population programs was
committed to HIV/AIDS during 2002–2006.
12
Empirical studies of this topic have at least two limitations.
First, they generally focus on inputs to the health care system,
such as human resources and capital resources, but neglect
outputs. Outputs are generally preferable to inputs as a mea-
sure of health system performance.
5 Second, most facility-
level studies use a pre-post design without a control group to
account for secular changes.
Using a quasi-experimental design with a matched control
group, we aim in this study to overcome these two limitations
with empirical data for six consecutive years (2002–2007) in
Rwanda to analyze the impact of HIV funding on the health
system. Rwanda provides a particularly informative research
context because the country has received substantial funding
from international donors to address HIV/AIDS and has been
used to support arguments on both sides.
7,13 This study also
contributes to the evaluation of other concurrent initiatives
in Rwanda, community-based health insurance (CBHI) and
performance-based financing (PBF).
METHODS
Study design. The analysis unit of the study was the health
center (HC). The overall study design was a pre-post compar-
ison between HIV/AIDS HCs (those in which HIV/AIDS
services began during the study period [2002–2007], excluding
the first and last years) and matched non-HIV/AIDS HCs
(which never offered HIV/AIDS services during the study
period). We assessed the impact of HIV/AIDS services by
comparing the evolution of non-AIDS inputs (personnel)
and outputs (services) between the two groups of HCs and
controlling for other covariates.
We used the date of starting antiretroviral therapy (ART)
service to mark the inception of comprehensive AIDS funding
in the HC. Twenty-five rural HCs starting ART services during
2002–2006 were randomly selected as the intervention group.
Based on the three matching factors (ownership, PBF [none, flat
or varied], and income of the district in which the HC is located
in 2002), we identified 25 perfectly matched HCs that had not
started HIV/AIDS services by the end of 2007. We excluded
urban HCs because all urban HCs provided HIV/AIDS services
by 2007. Thus, no urban HCs could serve as controls.
During June–September 2008, a trained research team col-
lected data from each HC. Most data were obtained during a
one-day site visit, but gaps were filled by follow-up phone
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902calls, and the records on vaccinations were obtained centrally
at the Ministry of Health (MoH).
Variables. We included two input and nine output indica-
tors in the evaluation. The inputs consisted of the number of
the full-time equivalent staff (FTE) on HIV/AIDS services,
termed HIV-personnel (HP), and on non-HIV/AIDS ser-
vices, called non-HIV personnel (NHP). The outputs covered
preventive and curative non-HIV/AIDS services. The indica-
tors for preventive services included the number of doses of
bacillus Calmette-Gue ´rin (BCG), diphtheria, pertussis, and
tetanus (DPT) vaccine, polio vaccine, and measles vaccine
that were distributed, and the number of visits for child
growth monitoring. The indicators for curative services were
the number of curative visits for persons < 5, 5–14, and > 14 years
of age and the number of admissions for hospitalizations. To
provide more stable measures of performance on non-HIV
services, we created summary indices for preventive services
and curative activities. Each index for a HC was the geometric
mean of the ratios of all included services within the HC
divided by the respective geometric means across all HCs.
For example, a preventive index of 2.0 meant that the HC
delivered on average twice the number of preventive services
as an average HC.
In addition to three matching variables (ownership, PBF,
income), we also included three contextual variables as
covariates to minimize the risk of confounding bias: 1) a proxy
for coverage of CBHI, 2) accessibility of the HC by bus
(busaccess), and 3) the background of the director in HCs
(background). The proxy for CBHI coverage was based on
the premium revenue from CBHI, the premium per person,
and the estimated population of the catchment area.
14 The
covariates and their coding are shown in Table 1.
Some data items remained missing (2.58%) despite follow-
up with the HCs and MoH offices, and some data were
categorized as outliers (beyond 1.5 times the interquartile,
2.43% of data). We imputed missing items by replacing them
by the mean of corresponding values from the two observa-
tions for which all other known information matched most
closely to the values for the observation with missing values,
a hot deck procedure.
15
Analysis. After calculating crude means of the evaluation
indicators by groups and years, we first conducted a simple
regression of the preventive and curative indexes as a function
purely of time to examine crude secular trends. We then devel-
oped fixed-effects and random-effects models to examine the
impact of HIV/AIDS funding, as shown in equation (1):
log indicatorit + 1 ðÞ = b0 + b1inti + b2afterARTit
+ b3inti*afterARTit + B4controlsit
+ ai + eit ð1Þ
In this equation, all the dependent variables except for
preventive and curative care indices are in started logarithm
form. Started logarithms are the natural logarithms of the
indicator plus 1, a transformation that permits relative com-
parisons while enabling zero values. The subscripts i and t
represent ith HC at year t, int*afterART is the interaction
term of int and afterART, and controls represents all other
control variables. The coefficient for int*afterART, b3, is the
target coefficient that informs the impact of the introduction
of ART services on the examined indicator. A statistically
significant positive coefficient of b3 would indicate an
enhancement effect of ART treatment on service delivery.
Conversely, a statistically significant negative coefficient of
b3 would imply the diversion effect of the ART service. To
minimize the risk of multiple comparisons, we focus attention
on the coefficients for the output variables related to the
interaction term (Int*afterART) and the two policy initiatives
in Rwanda, CBHI and PBF varied payment.
We conducted Hausman tests to determine whether fixed
or random effects fit the data better. To increase our ability to
examine patterns on the nine service outputs, we checked
consistency in direction in the results by applying Fisher’s
exact test to the signs of coefficients. To examine the impact
of time on service delivery, we estimated models with three
alternative specifications of the variable time in the formula: a
continuous variable, a dummy variable, or no time variable.
RESULTS
Descriptive analysis and comparison of trends. Detailed
descriptive statistics for all variables in the control and inter-
vention groups and the difference of growth rates between the
two groups using the data in the earliest and latest two years
are shown in Table 2. Over this four-year period (mid 2002–
mid 2006), AIDS HCs on average added five more staff pro-
viding AIDS services than non-AIDS HCs. However, the
number of personnel providing non-AIDS services increased
16% less in AIDS HCs than in non-AIDS HCs. For all the
output indicators, AIDS HCs tended to increase at a faster
rate than non-AIDS HCs.
To compare trends between AIDS HCs and non-AIDS
HCs, average scores of the preventive care index and trend
lines by group are shown in Figure 1. The trends were derived
from a simplified regression model using year (year), group
(int) and their interaction term (year*int) as the independent
variables. The graph shows a decrease in the control group
and an increase in the intervention group, indicating that
AIDS funding may promote the preventive services. How-
ever, the coefficient for the interaction term of 0.050 was not
statistically significant (P = 0.15).
Average scores of curative care index by group are shown
in Figure 2. In both groups, the provision of curative care
TABLE 1
Coding of categorical variables in the analysis, Rwanda*
Variable Coding
Int 0 = Control group, 1 = Intervention group
AfterART 0 = Before antiretroviral treatment started,
1 = After antiretroviral treatment started
Ownership 0 = Publicly owned, 1 = Privately owned
PBF† 0 = No PBF (no extra payment),
1 = Phase 1 (pay by results),
2 = Phase 2 (flat payment)
CBHI Continuous variable (0–100)
Income‡ 0 = Low income, 1 = Median income,
2 = High income
Busaccess 0 = No bus access, 1 = Bus access
Background§ 0 = A2 nurse, 1 = A1 nurse or medical doctor
*PBF = performance-based financing; CBHI = community-based health insurance.
†In the regression, dummy variables were generated. Health centers without PBF were
used as the reference group. Health centers in phases 1 and 2 received detailed monitoring of
services, those in phase 1 received conditional funding based on the volume of designated
services, and those in phase 2 received supplemental lump-sum funding.
‡In the regression, dummy variables were generated. Health centers located in the
median-income province were used as the reference group.
§A1 nurses have 3 years of nursing training post high school. A2 nurses have only high
school level nursing education.
HIV/AIDS FUNDING IN RWANDA 903increased over time. AIDS HCs increased slightly faster than
the control group, suggesting that inception of AIDS funding
potentially improved the delivery of curative care. Again,
however, the coefficient for the interaction term of 0.055 was
not statistically significant (P = 0.14).
Multiple regression analysis. After controlling for the
covariates, we found that the results were robust in all three
model specifications regarding whether and how secular trend
(time) was included in the model. Over the six years, no unan-
imous secular trend in service delivery was observed. There-
fore, the preferred model, reported here, used a reference year
of 2002 and a dummy variable for each subsequent year. We
also chose random effects over fixed effects models because
Hausman tests showed insignificant differences between the
random effects and fixed effects models (P > 0.05) for more
than half of indicators examined (6 of 11 indicators) and no
inconsistencies of signs and significance of the coefficients on
the key research variables (e.g., HIV*afterART and CBHI)
between the two types of models. Results from the models are
summarized in Table 3.
In Table 3, the interaction coefficients (int*afterART) for 7
of 9 services were positive. Using Fisher’s exact test, we found
that the probability of having such imbalanced results caused
by chance was only 8%, suggesting a trend towards AIDS
HCs experiencing faster growth on general health services.
The only service indicator that reached even borderline sta-
tistical significance (P = 0.06) was BCG vaccination. The
coefficient of 0.105 suggested that initiation of ART treat-
ment increased BCG vaccination by 10.5%. Although we
found negative coefficients for the interaction term in two
regression analyses (those on rates of services of curative care
of children < 5 years of age and on rates of hospitalizations),
neither coefficient was statistically significant. The results
from the two comprehensive indices were similar: introduc-
tion of HIV/AIDS care appeared to improve the delivery of
services related to preventive care and had no effect on those
related to curative care.
Regarding the number of full-time equivalent (FTE) per-
sonnel at the HCs, we found a significant difference between
the AIDS HCs and the control HCs: HIV programs reduced
non-HIV staff by 22%, but increased HIV staff by 85%. The
large percentage increase was an artifact of the small denom-
inators (small numbers of HIV staff) in the initial years. We
ran another model using the absolute number of HP and NHP
Table 2
Mean values of indicators by type of health center and time period, Rwanda*
Variable
Non-AIDS HC AIDS HC Growth rate (%)
Difference in
growth rates (%) 2002–2003 2006–2007 2002–2003 2006–2007 Non-AIDS AIDS
HIV personnel 0.0 0.0 0.5 5.5 –– –
Non-HIV personnel 9.5 13.5 13.7 17.0 42 26 −16
BCG doses 736 613 959 919 −17 −41 3
DPT doses 2,020 1,814 2,644 2,630 −10 −19
Polio doses 2,542 2,239 3,412 3,310 −12 −39
Measles doses 588 615 793 859 5 8 3
Curative care visits, < 5 years of age 1,794 3,040 2,179 4,023 69 85 16
Curative care visits, 5–14 years of age 778 1,505 917 2,140 94 133 39
Curative care visits, > 14 years of age 3,323 5,985 4,516 9,619 80 113 33
Growth monitoring visits 4,156 4,189 2,652 5,044 1 90 89
Hospitalization admissions 598 548 828 807 −8 −26
Preventive care index 0.827 0.763 0.903 1.036 −81 5 2 3
Curative care index 0.629 0.955 0.8 1.35 52 69 17
*Non-HIV denotes HCs without HIV services; HIV denotes HCs with HIV services, and difference is HIV-Non-HIV. AIDS = acquired immunodeficiency syndrome; HC = health center;
HIV = human immunodeficiency virus; BCG = Bacille Calmette-Gue ´rin; DPT = diphtheria, pertussis, and tetanus.
Figure 1. Average score of preventive care index between
acquired immunodeficiency syndrome (AIDS) AIDS centers and
Non-AIDS centers in Rwanda, 2002–2007.
Figure 2. Average score of curative care index between acquired
immunodeficiency syndrome (AIDS) AIDS centers and Non-AIDS
centers in Rwanda, 2002–2007.
904 SHEPARD AND OTHERSas dependent variables and found that the net impact of HIV/
AIDS program was a 2.7 FTE reduction of NHP (P < 0.01)
and a 3.3 FTE addition of HP (P < 0.001). The net result of 0.6
FTE staff indicated that overall health personnel increased in
AIDS HCs compared with control HCs.
From the additional covariates, we found that CBHI
uniformly improved use of curative care across all age groups
(P < 0.05). Similarly, we observed a statistically significant
favorable impact of CBHI on the curative care index. A 1%
point increase of CBHI use rate improved curative care for
population < 5, 5–14, and > 14 years of age by 0.5%, 0.7% and
0.7%, respectively. Surprisingly, CBHI was associated with
a slight reduction in the number of measles vaccinations
(coefficient = –0.003, P < 0.05).
Performance-based financing was another important factor
in improving service delivery, particularly the version with
payment according to numbers of services being provided.
Compared with HCs without PBF schemes, HCs in PBF
phase 1 delivered 11.4% more DPT vaccines (P < 0.05),
10.6% more polio vaccines (P < 0.10), 19.1% more curative
care for children < 5 years of age (P < 0.10) and 34.5% more
hospitalization care (P < 0.10).
DISCUSSION
This study shows that for most indicators examined, there
were neither prominent diversion nor enhancement effects after
AIDS services were inaugurated in HCs in Rwanda. The results
are consistent with those from studies in several other countries
in Africa, where substantial infusions of AIDS-related funding
did not adversely affect non-AIDS services. For example, in
Ethiopia, although the influx of funding for HIV/AIDS might
have encouraged physician migration from the public to the
non-governmental organization sectors, there is no evidence of
adverse effects for the health system overall: mortality
decreased, coverage of immunization increased, and antenatal
care coverage increased over the four-year period of HIV
expansion (2003–2007).
16 In the U.S. President’s Emergency
Plan for AIDS Relief (PEPFAR) focus countries, non–HIV-
specific national health indicators compared with non-PEPFAR
focus countries showed no evidence that PEPFAR funding
had negative impacts on non-HIV health parameters.
17,18
Our study shows that BCG vaccination is the only one of all
the services examined with a statistically significant interac-
tion term. Surprisingly, the number of BCG vaccinations
decreased in both control and intervention HCs in our sam-
ple, albeit with smaller reduction in AIDS-HCs than control
HCs. The downward trend from our sample of rural HCs in
numbers of vaccinations contrasts with national reports by
the World Health Organization and the United Nations Chil-
dren’s Fund, which indicated a 2.5% increase per year in BCG
vaccination rates in Rwanda in 2006 and 2007.
19 For vaccina-
tions with high coverage in Rwanda, such as DPT, measles,
and polio,
19 we expected no significant improvement because
these services are saturated. We did not observe such a
decrease for vaccinations in this study in AIDS HCs. Integra-
tion of HIV/AIDS services with other HC activities may have
helped follow-up of missed vaccinations in AIDS HCs.
Absolute numbers of vaccinations were likely reduced by
decreases in numbers of infants born after substantial growth
in Rwanda of use modern methods of family planning and
decreases in its total fertility rate during this study period
and subsequently.
20,21
The study showed less use of curative ambulatory care for
children < 5 years of age and in hospitalizations in the interven-
tion group, although neither coefficient approached statistical
significance. Given the high prevalence of infectious diseases
and increased mortality rate among children in Rwanda in
2003,
22 and subsequent reduction in the child mortality rate
from 153 to 103 per 1,000 live births from 2005 to 2007 and 76
in 2010,
20,21 these patterns could reflect lesser need for curative
care from the combined effects of AIDS funding and other
government policies such as CBHI, PBF, and development of
an effective network of community health workers.
From the descriptive analysis, we observed that the behav-
ior of seeking care for children < 5 years of age in the inter-
vention and control groups increased from the pre-period to
Table 3
Estimated coefficients in regression models, Rwanda*
Independent
variable
HIV
personnel
Non-HIV
personnel BCG DPT Polio Measles
Curative
care
visits < 5
Curative
care visits
5–14
Curative
care
visits > 14
Growth
monitoring Hospitalization
Preventive
care index
Curative
care
index
Int 0.736† 0.304† 0.279‡ 0.335† 0.339† 0.293† 0.209 0.196 0.264‡ 0.035 0.850 0.153 0.291‡
AfterART −0.414‡ 0.042 −0.154‡ 0.003 −0.024 −0.045 0.017 0.023 −0.066 −0.142 −0.442§ −0.044 −0.164
Int*afterART 0.858† −0.222† 0.105§ 0.005 0.036 0.045 −0.009 0.077 0.118 0.049 −0.278 0.109§ 0.084
Ownership 0.146 0.153 −0.030 −0.024 −0.037 −0.069 −0.047 −0.116 0.059 0.815 0.671 0.087 0.121
No PBF (reference)
PBF varied
payment
−0.145 −0.034 0.008 0.114‡ 0.106§ 0.068 0.191§ 0.205 0.135 0.603 0.345§ 0.084 0.198‡
PBF flat
Payment
0.004 −0.003 −0.027 0.005 −0.013 −0.028 0.060 0.084 0.040 0.168 −0.017 0.008 0.126‡
CBHI 0.002 0.003§ −0.001 −0.001 −0.001 −0.003
† 0.005† 0.007† 0.007† 0.005 −0.002 −0.002 0.006†
Middle income (reference)
Low income −0.184§ −0.173 0.064 0.05 0.033 0.021 −0.051 0.026 −0.034 −0.377 −0.257 0.06 0.006
High income 0.056 −0.204§ 0.047 −0.040 −0.043 −0.127 −0.140 −0.276§ −0.242 −1.136 −0.129 −0.064 −0.218
Busaccess 0.096 0.018 0.102 0.102 0.081 0.059 0.130 0.215 0.230 −0.376 −0.585 0.012 −0.049
Background 0.140 0.322‡ 0.205§ 0.073 0.112 0.272† 0.241 0.140 0.233 1.363§ 0.211 0.355† 0.119
*Dependent variables were the started logarithm of number of services per year in each health center except preventive and curative care index. Each regression model also included a
constant term and dummy variables for each year after the reference year (2002). HIV = human immunodeficiency virus; BCG = Bacille Calmette-Gue ´rin; DPT = diphtheria, pertussis, and
tetanus; PBF = performance-based financing; CBHI = community-based health insurance. We used a = 0.10 because we had only 50 health centers in the study.
†P < 0.01.
‡P < 0.05.
§P < 0.10.
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dren’s mortality rate, of which the major causes are malaria,
measles, being underweight, and HIV/AIDS. The slightly
lower increase in curative services for children < 5 years of
age in the intervention group observed in multiple regressions
might be attributed to the higher coverage of preventive ser-
vices in intervention HCs because the demand for curative
care decreased, whereas preventive primary care is strength-
ened. For example, with malaria as the major reason for hos-
pitalization, the decrease likely represents better prevention
and management of malaria.
Infusion of HIV/AIDS funding in Rwanda comes in the
context of concurrent beneficial interventions (e.g., CBHI
and PBF) in the health sector. Consistent with previous
reports,
23,24 our results suggest that higher coverage of health
insurance was associated with improved use of curative ser-
vices by the rural population in Rwanda. Similarly, analysis by
an overlapping group of researchers showed that provinces
with greatest increases in CBHI enrollment experienced the
greatest reductions in malaria mortality (Shepard DS,
Rwiyereka AK, Bail RN, and Kagubare J, unpublished data).
Because childhood vaccinations are provided free to all chil-
dren, regardless of insurance coverage, we did not expect any
effect of CBHI on preventive services. The unexpected nega-
tive coefficient for CBHI on measles vaccinations was small
and did not apply to any other vaccinations. Given the impor-
tance of CBHI in seeking essential care in many developing
countries, international donors may consider premium subsi-
dies and other approaches to increase enrollment by the most
vulnerable populations.
Consistent withfindings from studies of PBF inRwanda,
25–27
our results also show that PBF exerts remarkable impact on
several services examined in this study, particularly on curative
care. In many developing countries, lack of incentives of med-
ical providers, scarcity of infrastructure, and shortage of medi-
cal workers are major constrains of providing essential medical
services to needy populations.
28 Reforming physician incen-
tives by paying for outputs to circumvent these constraints has
been initiated in several resource-limited countries besides
Rwanda, such as Haiti and Afghanistan, and has shown
favorable results.
28–30
Although we used a quasi-experimental research design,
our study still contains three limitations. The first is the inabil-
ity to observe a counter-factual: what would have occurred for
non-HIV/AIDS service in the absence of the HIV/AIDS pro-
grams.
11 It is possible that without HIV/AIDS programs, HCs
in both groups might have received more resources for other
services. In considering the experiences of the control HCs as
the counter-factual, we implicitly assume that the injection of
HIV/AIDS funding at a higher level in the health system (e.g.,
national or district level) does not affect its resource alloca-
tion to the non-HIV HCs. The second limitation lies in not
including system-level inputs. HIV/AIDS programs may
strengthen health care systems with improved information
system, drug procurement, management, leadership, gover-
nance, and standardized health care procedures.
3,6 However,
because many elements of system performance are difficult
to measure, and may offer benefits to comparison HCs,
their impacts are not included. The third limitation is that this
study involved only one country (Rwanda), lasted less than a
decade, and overlapped in time with implementation of
other beneficial interventions, especially CBHI. The policy in
Rwanda of integrating HIV/AIDS care with general health
services and its generous support from donors may have con-
tributed to widespread service improvements. It is possible
that without these concurrent interventions, or in a country
with different cultural factors, the effect of HIV/AIDS ser-
vices on outputs could have been less favorable.
Despite these limitations, this study found that the injection
of AIDS funding did not reduce provision of curative and
preventive services over this six-year period in Rwanda. For
most non-HIV/AIDS services, we observed improvements
after HIV/AIDS funding. To address the challenges posed by
HIV/AIDS in Rwanda requires maintaining the momentum
to continue to increase resources for this health problem.
Equally important is the integration of HIV/AIDS funding
with the health care system to benefit all other diseases to
maximize the positive synergies of HIV/AIDS programs and
health systems.
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